Insulin glargine and lixisenatide Subcutaneous and Nadostine Sucrose-Free
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Nadostine Sucrose-Free and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: nystatin
Brand name: Bio-Statin, Mycostatin
Synonyms: Nadostine Sucrose-Free (Oral), Nystatin (Oral), Nystatin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Nafcil
- Insulin glargine and lixisenatide Subcutaneous-Nafcillin
- Insulin glargine and lixisenatide Subcutaneous-Nafcillin injection
- Insulin glargine and lixisenatide Subcutaneous-Nafcillin Sodium
- Insulin glargine and lixisenatide Subcutaneous-Nalbuphine
- Insulin glargine and lixisenatide Subcutaneous-Nalbuphine Hydrochloride
- Nadostine Sucrose-Free-Insulin glargine, recombinant Subcutaneous
- Nadostine Sucrose-Free-Insulin glulisine
- Nadostine Sucrose-Free-Insulin Glulisine (Cartridges and Pens)
- Nadostine Sucrose-Free-Insulin Glulisine (Vials)
- Nadostine Sucrose-Free-Insulin glulisine Subcutaneous
- Nadostine Sucrose-Free-Insulin human inhaled Inhalation